Browsing Category
Pharma Industry News
4739 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Caribou Biosciences set for key webcast showcasing CRISPR-engineered CAR-T breakthroughs in blood cancers
Discover how Caribou Biosciences is preparing to reveal breakthrough CRISPR-edited allogeneic CAR-T data in lymphoma and myeloma during its investor webcast.
Merger war explodes: Pfizer drags Metsera and Novo Nordisk to court over ‘illegal’ bid
Pfizer takes legal action against Metsera and Novo Nordisk over breach of merger terms. Find out how this battle could reshape obesity drug M&A.
Fridge-free vaccine milestone: Stablepharma locks Phase I SPVX02 data in thermostability push
Stablepharma has completed its first human trial for SPVX02, a fridge-free tetanus-diphtheria vaccine designed to work without cold-chain storage. With the data now locked, the company is preparing to scale its thermostable platform for global deployment.
Otsuka ICU Medical’s potassium chloride recall: What went wrong with Lot 1030613?
Otsuka ICU Medical recalls mislabeled potassium chloride injection due to overdose risk. Healthcare providers must act now to avoid serious patient harm.
Is Merck building the next great cardiometabolic franchise? A closer look at WINREVAIR, enlicitide and Ohtuvayre
See how Merck is building a cardiometabolic growth engine with WINREVAIR, enlicitide and Ohtuvayre—and what it means for investors.
First patient dosed in Adagene’s Phase 2 study of Muzastotug (ADG126) with KEYTRUDA for microsatellite stable colorectal cancer
Find out how Adagene’s Muzastotug and KEYTRUDA combination could redefine immunotherapy for microsatellite stable colorectal cancer.
How Cosmos Health’s nanotechnology breakthrough could transform absorption and performance in plant-based supplements
Discover how Cosmos Health’s solvent-free nanotechnology platform is redefining supplement science with higher absorption, cleaner manufacturing, and proven phytochemical efficacy.
Amgen’s landmark Repatha trial to take center stage at AHA 2025 with major cardiovascular prevention results
Find out how Amgen’s Repatha phase 3 trial is redefining cardiovascular prevention and reshaping investor sentiment at AHA 2025.
BioStem Technologies unveils top-line data proving BioRetain allograft’s superior healing benefits in diabetic foot ulcers
Find out how BioStem Technologies’ BioRetain allograft is improving diabetic foot ulcer healing outcomes and shaping regenerative wound care.
Vesper Bio reports 95% CSF progranulin boost in FTD-GRN trial—what’s next for VES001?
Vesper Bio’s oral FTD therapy VES001 boosts CSF progranulin by 95%. Explore what this means for dementia prevention and future clinical milestones.